PharOS Overview
- Founded
-
2002

- Status
-
Private
- Employees
-
187

- Latest Deal Type
-
PE Growth
- Financing Rounds
-
1
PharOS General Information
Description
Manufacturer of generic pharmaceutical and value-added products intended to extend the lifecycle of the product. The company offers various products including antivirals, antidiabetics, antipsychotics, antidepressants and oncology medicines that are sold throughout the world to meet the pharma industry's demanding requirements, ensuring its clients with the success in completing challenging projects through intellectual property rights and developments.
Contact Information
Website
www.pharosgr.gr
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
- Lesvou Street, Thesi Loggos
- Industrial Zone
- Metamorfossi Attikis, 144 52
- Greece
+30 21 0000 0000
PharOS Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
PharOS Patents
PharOS Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3793530-A1 | Solid dispersion containing ritonavir | Pending | 18-May-2018 | 0000000000 | |
EP-3569225-A1 | Solid dispersion containing ritonavir | Withdrawn | 18-May-2018 | 0000000000 | |
EP-3419605-A1 | Dasatinib formulation | Pending | 25-Feb-2016 | 0000000000 | |
GB-201304699-D0 | Pharmaceutical compositions | Ceased | 15-Mar-2013 | 0000000000 | |
EP-2968175-A1 | Pharmaceutical compositions comprising imatinib | Withdrawn | 15-Mar-2013 | A61K31/506 |
PharOS Executive Team (5)
PharOS Signals
PharOS Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|